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19th CardioVascular Summit: TCTAP 2014development and the introduction of the echo or IVUS guided EVT. But now this is still
challenging. In the diagnosis of peripheral artery disease, duplex ultrasonography is
noninvasive, simple and usefulness, but it was impossible to assess the lesion morphology.
Elastography is an ultrasonographic method that has been examined as a diagnostic tool
for breast lesions. We applied this method to hardness measurement of CTO lesions by
our original method. Our aim was to investigate the usefulness of the ultrasonography
(US) “vascular elastography (VE)” in EVT for long CTO lesions of SFA.
Methods: In 1274 consecutive cases which underwent EVT between April 2010 and
May 2013, we focused on 57 cases of EVT for long CTO of femoropopliteal arteries,
which CTO length was more than 150mm. We assessed the CTO lesions by duplex
US and “VE” about lesion hardness with our original methods before procedure. US
was performed with 8 MHz linear transducer (Aprio XG/500, TOSHIBA, Japan), and
off-line analysis of “VE” was performed with elasto-Q (TOSHIBA, Japan). We
originally categorized into ﬁve types by original VE score. The ratio of hard
appearance portion (VE score 0-1) to CTO (H/T ratio) was evaluated. Comparing
investigation about procedure results was performed between hard group (H group:
hard portion>20%) and non-hard group (NH group: hard portion<20%). In EVT,
guide wire was penetrated with US guided from body surface without ﬂuoroscopy.
Results: We could assess elastogram of target CTO lesions in all cases (H group: 27
cases, S group: 30 cases). No signiﬁcant difference was detected in CTO lesion length
(H: 28.96.8mm, S: 26.64.7mm). Hard portions were detected in CTO lesions (H:
10.26.9mm, H/T ratio 32.515.8% vs. S: 1.81.8mm, H/T ratio 7.36.6%;
p<0.001). Operation time in H group was longer than S group (H: 248.0115.1min
vs. S: 142.942.1min; p¼0.01). Success rate was H: 92.6% vs. S: 100%. No sig-
niﬁcant difference was detected in case of retrograde approach from popliteal artery
(H: 29.6%, S: 10.0%). Retrograde approach was needed in only 17 cases which distal
site of CTO was VE score 0 to 2 (VE score 0-2: 29.8% vs. 3-4: 0%; p<0.01).Cases in
S group could be penetrated with hydrocoat soft guidewire (12.1% vs. 65.2%;
p<0.001). In 11 cases, CTO site was all soft appearance as VE score 3 to 4. A hy-
drophilic soft guide wire could pass the lesion easily.
Conclusion: “Vascular Elastography” might be able to predict the difﬁculty of EVT,
useful when we decide strategies and selections of device because we could assess
the vascular morphology noninvasively before procedure. VE could detect the hard
plaque which difﬁcultly penetrated without calciﬁcation.
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Background: The iodinated contrast volume can cause an exacerbation of the renal
function. Previous report has demonstrated CO2 guided angioplasty to effectively
reduce the amount of contrast volume. However, in general CO2 angiography, the image
quality tends to be poor, especially in the renal artery. As a result of such poor images, the
procedure time when performing CO2 angiography thus becomes prolonged. We
therefore evaluated the efﬁcacy and safety of the contrast media used when performing
endovascular therapy with CO2 digital subtraction angiography in CKD patients.
Methods: A prospective multicenter registry was performed for CO2 guided angi-
ography of the renal artery or iliofemoral angioplasty. Patients with estimated an
Glomerular Filtration Rate ( eGFR) <60ml/min/1.73m2 were recruited for this study.
The patients in the CO2 registry were divided into either the Co2 only group or the
Co2+contrast group. Comparisons were made between each group, regarding the
procedures and any serial changes in the renal function. An exacerbation of the renal
function was thus deﬁned as a 25% decline in the creatinine level at three months We
evaluated the efﬁcacy and safety of the contrast media used for endovascular therapy
with CO2 Digital subtraction angiography in CKD patients.
Results: A total of 92 patients were divided into the CO2 only group (N¼37) and the
CO2+contrast group (N¼55). The age was 75.27.3 years old in the CO2 only group
and 75.28.61 years old in the CO2+contrast group. There were 94 target lesions in
the CO2 only group (aorto-iliac arteries: 27, femoro-popliteal arteries: 54, renal ar-
teries: 13), while there were 86 lesions in the Co2+contrast group (aorto-iliac arteries:
15, femoro-popliteal arteries: 58, renal arteries: 13). The contrast volume in the CO2
only group was 0 ml, while it was 24.916.9 ml in the CO2+contrast group (P<0.01).
The procedure time was 25.019.1 min in the CO2 only group, and 20.815.1 min in
the CO2+contrast group (P¼ns). The CO2 dose in the CO2 only group was
333.1143.6 ml, 235.3 142.0 ml in the CO2+contrast group (P<0.01). A decline in
the renal function was observed at three months in 1 patient in the CO2 only group
and in 4 patients in the CO2 contrast group (P¼Ns). According to a univariate
analysis, the only predictor of a decline in the kidney function was only the serum
creatinine level that was obtained before intervention.
Conclusion: A small contrast volume used during CO2 angiography for endovascular
therapy therefore was not found to exacerbate the renal function at three months. The
only predictor of a decline in the kidney function was therefore determined to be the
serum creatinine level that was obtained before intervention.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORATCTAP A-103
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Background: Pulse pressure (PP) is one of strong predictors of arterial stiffness and
atherosclerosis. It has been reported that a 10 mmHg increase in PP increased the risk
of major cardiovascular complications and mortality by nearly 20%. However, clinical
signiﬁcance of wide PP difference deﬁned as PP  100mmHg following endovascular
intervention (EVT) for patients with critical limb ischemia (CLI) are not clariﬁed yet.
Methods: A total 286 consecutive patients with CLI for EVT from August 2004
to November 2012 were enrolled for this study. PP was calculated by subtracting the
diastolic pressure from the systolic pressure of a brachial artery. A total 52 patients
(18.2%) had PP  100mmHg. We compared the angiographic and clinical outcomes
of patients with PP  100mmHg to those with PP < 100mmHg at 12-months.
Results: The baseline characteristics are well balanced between the two groups except
Ankle brachial index which was lower in the PP  100mmHg group (Table 1). At 12
months, although the incidence of mortality, target lesion revascularization (TLR),
target extremity revascularization (TER), and limb salvage rate were similar between
the two groups, the patients who had PP  100mmHg had higher incidence of binary
restenosis and showed lower primary patency and secondary patency than those who
had PP <100mmHg (Table 2).
Conclusion: Higher PP was associated with lower ABI, higher restenosis rate and
lower patency at 1 year, suggesting more intensive medical therapy with close clinical
follow up will be required for patients with PP  100mmHg following EVT.TCTAP A-104
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Background: To investigate the clinical outcomes of endovascular therapy (EVT)
with drug eluting stents (DES) for all-comers with femoropopliteal (FP) disease.
Methods: This is a single center, retrospective study. Between July 2012 and April
2013, 83 patients (54 men; mean age 74 years) underwent stent implantation for 115
FP lesions in 102 limbs with Cook Medical’s self-expanding Zilver PTX paclitaxel-
eluting nitinol stent. 42 patients(51%) were diabetic and 20 patients(24%) were on
hemodialysis. 29 patients(28%) had critical limb ischemia (CLI). 44% were TASC C
or D (C,18%; D,26%) Mean lesion length and diameter were 13694 mm and
5.71.0 mm. We evaluated the clinical outcomes. Restenosis was assessed by either
duplex ultrasound or angiography. Sub-analysis for the risk factor of restenosis was
also performed.
Results: Patients were followed up for 63 months. Restenosis occurred in 10 lesions
(8.7%). Occlusion occurred in 6 lesions (5.2%). The incidence of target lesion revas-
cularization was 5.2%. Major adverse limb events occurred in 7 cases (6.9%) (FP
bypass grafting, 2 cases; major amputation, 5 cases). No stent thrombosis occurred in 90
days. 2 major complication (1 distal embolism and 1 hematoma requiring bloodL/Peripheral Vascular Intervention (Non-carotid, Non-neurovascular) S29
